Icon plc Stock
Icon plc gained 0.930% compared to yesterday.
Icon plc is currently one of the favorites of our community with 18 Buy predictions and no Sell predictions.
As a result the target price of 318 € shows a slightly positive potential of 12.89% compared to the current price of 281.7 € for Icon plc.
Pros and Cons of Icon plc in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Icon plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Icon plc | 0.930% | -3.392% | -10.401% | 59.531% | 7.969% | - | - |
| Alkermes plc | -0.870% | 0.000% | -8.065% | -10.236% | -8.800% | 27.374% | -14.925% |
| Ironwood Pharmaceuticals | 0.690% | -2.685% | -8.228% | -22.872% | -28.922% | -21.622% | - |
| Sage Therapeutics Inc. | -3.520% | 7.851% | -25.000% | -69.792% | -34.750% | -79.867% | - |
Comments
ICON Public Limited (NASDAQ: ICLR) had its price target raised by analysts at TD Cowen from $343.00 to $349.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ICLR provided by MarketBeat
ICON Public Limited (NASDAQ: ICLR) had its price target lowered by analysts at Evercore ISI from $350.00 to $330.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ICLR provided by MarketBeat
ICON Public Limited (NASDAQ: ICLR) had its price target raised by analysts at Robert W. Baird from $362.00 to $363.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ICLR provided by MarketBeat
News
ICON Announces Pricing of USD 2 Billion Notes
ICON plc (NASDAQ: ICLR) (“ICON”), a world-leading healthcare intelligence and clinical research organization, today announced the pricing of a USD 2 billion SEC-registered bond offering, consisting
ICON Reports First Quarter 2024 Results
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today reported its financial results for the first quarter ended March 31, 2024.
CEO, Dr
ICON Announces CFO Transition
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that Chief Financial Officer, Brendan Brennan, will leave his role at ICON in